| |
| |
|
| Insider
Information: |
Ryan Jason |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
188,356 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$4,040,236 |
|
|
| Total
Shares |
188,356 |
|
|
| Total
Value |
$4,040,236 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
3
|
|
Stock
price went up :
|
2
|
1
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
2.0
|
| Percentage
Gain/Loss : |
 1,230.7%
|
378.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Foundation Medicine, Inc. |
FMI |
Chief Financial Officer |
2018-07-31 |
0 |
2014-04-16 |
0 |
Premium* |
|
|
GeneDx Holdings Corp |
WGS |
Director |
2024-01-11 |
0 |
2024-01-11 |
188,356 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
78 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2017-03-16 |
4 |
S |
$31.68 |
$396,000 |
D/D |
(12,500) |
52,980 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2017-01-04 |
4 |
S |
$18.49 |
$26,367 |
D/D |
(1,426) |
54,757 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2018-04-03 |
4 |
S |
$72.40 |
$72 |
D/D |
(1) |
56,022 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2018-04-02 |
4 |
AS |
$74.87 |
$467,959 |
D/D |
(6,139) |
56,023 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2017-01-03 |
4 |
S |
$17.41 |
$56,391 |
D/D |
(3,239) |
56,183 |
0 |
- |
|
| WGS |
GeneDx Holdings Corp |
Executive Chairman |
• • – |
2023-11-16 |
4 |
B |
$1.27 |
$72,187 |
I/I |
56,742 |
56,742 |
2.66 |
% |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2018-03-15 |
4 |
OE |
$29.63 |
$444,450 |
D/D |
15,000 |
57,083 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2016-10-20 |
4 |
AS |
$22.45 |
$11,360 |
D/D |
(506) |
59,422 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2016-10-04 |
4 |
S |
$23.65 |
$28,853 |
D/D |
(1,220) |
59,928 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2016-08-19 |
4 |
S |
$23.91 |
$331,614 |
D/D |
(13,863) |
61,148 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2018-04-01 |
4 |
A |
$78.75 |
$1,018,395 |
D/D |
12,932 |
62,162 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2017-10-02 |
4 |
S |
$38.80 |
$122,375 |
D/D |
(3,154) |
63,484 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2018-02-15 |
4 |
OE |
$29.63 |
$444,450 |
D/D |
15,000 |
64,230 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2017-03-16 |
4 |
OE |
$0.84 |
$41,210 |
D/D |
12,500 |
65,480 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2016-08-19 |
4 |
OE |
$7.12 |
$35,600 |
D/D |
5,000 |
66,148 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2017-07-13 |
4 |
AS |
$39.77 |
$202,191 |
D/D |
(5,084) |
66,638 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2018-01-16 |
4 |
OE |
$29.63 |
$592,600 |
D/D |
20,000 |
69,230 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2016-07-05 |
4 |
S |
$18.26 |
$23,190 |
D/D |
(1,270) |
70,011 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2016-07-01 |
4 |
S |
$17.39 |
$59,422 |
D/D |
(3,417) |
71,281 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2017-12-05 |
4 |
OE |
$0.08 |
$133,302 |
D/D |
21,726 |
71,289 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2017-07-06 |
4 |
S |
$38.84 |
$259,568 |
D/D |
(6,683) |
71,722 |
0 |
- |
|
| WGS |
GeneDx Holdings Corp |
Executive Chairman |
• • – |
2023-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
67,780 |
73,614 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2016-04-01 |
4 |
A |
$18.25 |
$821,250 |
D/D |
45,000 |
74,698 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2017-06-02 |
4 |
AS |
$40.00 |
$222,920 |
D/D |
(5,573) |
78,405 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2017-05-01 |
4 |
A |
$35.80 |
$1,171,877 |
D/D |
32,734 |
83,978 |
0 |
- |
|
78 Records found
|
|
Page 3 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
